SYK Stock Analysis: Buy, Sell, or Hold?
SYK - Stryker Corporation
$305.05
2.96 (0.98%)
▲
5d:
+3.68%
30d:
-10.61%
90d:
-16.62%
BUY
HIGH Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: Jul 30, 2026
Smart Money Accumulation
SYK is down 4.6% this week, but smart money is accumulating calls. Top strike: $410 2026-06-18 with 437 OI. Call ratio: 64% View Scanner →
Strength: 3.7/10
Get Alerted When SYK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SYK trading at deep discount. Market pricing in -6.1% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: SYK trading at deep discount. Market pricing in -6.1% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$529.98
Based on 7.8% avg growth
INTRINSIC VALUE TODAY
$329.08
7.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 21.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SYK is currently trading at $305.05, which is considered slightly low relative to its 30-day fair value range of $299.08 to $340.16. From a valuation perspective, the stock is trading at a discount (Forward PE: 18.1) compared to its historical average (21.8). Remarkably, the market is currently pricing in an annual earnings decline of 6.1% over the next few years. This pessimistic expectation contrasts with the company's recent 14.2% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, SYK is in a strong downtrend. The price is approaching resistance at $313.34. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $392.19 (+29.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SYK is in a strong downtrend. The price is approaching resistance at $313.34. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $392.19 (+29.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$299.08 -
$340.16
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 29.8% below Wall St target ($392.19)
Trading Range Analysis
30-Day Trading Range
$299.08 -
$340.16
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$281.00
Resistance Level
$313.34
Current Trend
Strong Downtrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.06
Wall Street Target
$392.19
(+29.8%)
Revenue Growth (YoY)
2.6%
Earnings Growth (YoY)
14.2%
Profit Margin
13.2%
Valuation Discount vs History
-6.1% cheaper
PE vs Historical
18.1 vs 21.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-6.1%
(market-implied from PE analysis)
1-Year Target
$283.66
(-6%)
2-Year Target
$266.36
(-12%)
3-Year Target
$250.11
(-17%)
3-Yr Target (if PE normalizes)
(PE: 18→22)
$301.88
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.0, Growth: 11.6%)
$512.73
(+70%)
Base:
(SPY PE: 18.1, Growth: 11.6%)
$420.18
(+39%)
Bear:
(PE: 15.4, Growth: 11.6%)
$357.15
(+18%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (33x PE), but valuation improves significantly next year (18x PE) as earnings recover.
Trailing PE: 32.67 | Current EPS (TTM): $8.65
Bull Case
$601.04
(+99%)
Analyst growth 93.4%, PE expands to 35.9
Base Case
$546.40
(+81%)
Market implied 93.4%, PE stable at 32.7
Bear Case
$192.15
(-36%)
Severe decline -20.0%, PE contracts to 27.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 18.1 to 21.8
Stabilization Target:
$364.62
(+20.7%)
PE Expansion Potential:
+20.7%
Share & Embed Analysis
Last updated: May 14, 2026 3:40 PM ET
Data refreshes hourly during market hours. Next update: 4:40 PM
Data refreshes hourly during market hours. Next update: 4:40 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SYK showing a specific setup today?
Insider Activity (6 Months)
4
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
BUY
2026-02-24
Ro Khanna
BUY
2026-02-17
Ronda E Stryker
SELL
250000 shares
2026-02-04
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 55 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$84 | 60 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 53 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$250 | 58 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$80 | 60 HOLD |
Advanced SYK Option Strategies
Professional options setups generated by AI based on today's SYK price and gamma walls.
